Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts

por Cardnell, Robert J. G., Mikkelsen, Ross B.
Publicado 2011

Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers

por Cardnell, Robert J., Byers, Lauren Averett, Wang, Jing
Publicado 2019

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

por Kundu, Kiran, Cardnell, Robert J., Zhang, Bingnan, Shen, Li, Stewart, C. Allison, Ramkumar, Kavya, Cargill, Kasey R., Wang, Jing, Gay, Carl M., Byers, Lauren A.
Publicado 2021

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

por Byers, Lauren Averett, Horn, Leora, Ghandi, Jitendra, Kloecker, Goetz, Owonikoko, Taofeek, Waqar, Saiama Naheed, Krzakowski, Maciej, Cardnell, Robert J., Fujimoto, Junya, Taverna, Pietro, Azab, Mohammad, Camidge, David Ross
Publicado 2017

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

por Cardnell, Robert J., Feng, Ying, Mukherjee, Seema, Diao, Lixia, Tong, Pan, Stewart, C. Allison, Masrorpour, Fatemeh, Fan, YouHong, Nilsson, Monique, Shen, Yuqiao, Heymach, John V., Wang, Jing, Byers, Lauren A.
Publicado 2016

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

por Cargill, Kasey R., Stewart, C. Allison, Park, Elizabeth M., Ramkumar, Kavya, Gay, Carl M., Cardnell, Robert J., Wang, Qi, Diao, Lixia, Shen, Li, Fan, You-Hong, Chan, Wai Kin, Lorenzi, Philip L., Oliver, Trudy G., Wang, Jing, Byers, Lauren A.
Publicado 2021

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other...

por Cardnell, Robert J., Li, Lerong, Sen, Triparna, Bara, Rasha, Tong, Pan, Fujimoto, Junya, Ireland, Abbie S., Guthrie, Matthew R., Bheddah, Sheila, Banerjee, Upasana, Kalu, Nene N., Fan, You-Hong, Dylla, Scott J., Johnson, Faye M., Wistuba, Ignacio I., Oliver, Trudy G., Heymach, John V., Glisson, Bonnie S., Wang, Jing, Byers, Lauren A.
Publicado 2017

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

por Stewart, C. Allison, Tong, Pan, Cardnell, Robert J., Sen, Triparna, Li, Lerong, Gay, Carl M., Masrorpour, Fatemah, Fan, You, Bara, Rasha O., Feng, Ying, Ru, Yuanbin, Fujimoto, Junya, Kundu, Samrat T., Post, Leonard E., Yu, Karen, Shen, Yuqiao, Glisson, Bonnie S., Wistuba, Ignacio, Heymach, John V., Gibbons, Don L., Wang, Jing, Byers, Lauren Averett
Publicado 2017

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

por Pietanza, M. Catherine, Waqar, Saiama N., Krug, Lee M., Dowlati, Afshin, Hann, Christine L., Chiappori, Alberto, Owonikoko, Taofeek K., Woo, Kaitlin M., Cardnell, Robert J., Fujimoto, Junya, Long, Lihong, Diao, Lixia, Wang, Jing, Bensman, Yevgeniva, Hurtado, Brenda, de Groot, Patricia, Sulman, Erik P., Wistuba, Ignacio I., Chen, Alice, Fleisher, Martin, Heymach, John V., Kris, Mark G., Rudin, Charles M., Byers, Lauren Averett
Publicado 2018

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

por Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Publicado 2021

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

por Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Publicado 2021